Stem cell banking: Between traceability and identifiability

Genome Medicine

Volumn 2, Issue 10, 2010, Pages

  Knoppers, Bartha M ^a   Isasi, Rosario ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE FACILITY; HUMAN; INFORMED CONSENT; INTERNATIONAL COOPERATION; LEGAL ASPECT; MEDICAL ETHICS; POLICY; PRIORITY JOURNAL; REVIEW; STEM CELL;

EID: 78751698531     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm194     Document Type: Review

References (57)

1. Hipp J, Atala A. Sources of stem cells for regenerative medicine. Stem Cell Rev 2008, 4:3-11. 10.1007/s12015-008-9010-8, 18286392.
2. Day JG, Stacey GN. Biobanking. Mol Biotechnol 2008, 40:202-213. 10.1007/s12033-008-9099-7, 18780190.
3. Organisation for Economic Co-operation and Development The Bioeconomy to 2030: Designing A Policy Agenda 2009. Organisation for Economic Co-operation and Development., http://www.oecd.org/document/48/0,3343,en_2649_36831301_42864368_1_1_1_1,00.html
4. Sermon KD, Simon C, Braude P, Viville S, Borstlap J, Veiga A. Creation of a registry for human embryonic stem cells carrying an inherited defect: joint collaboration between ESHRE and hESCreg. Hum Reprod 2009, 24:1556-1560. 10.1093/humrep/dep062, 19346524.
5. Reproductive Genetics Institute Stem Cell Bank. , http://reproductivegenetics.com/stem_cell_bank.html
6. WiCell Research Institute WISC Bank. , http://www.wicell.org/index.php?option=com_oscommerce&Itemid=192#iPS
7. Isasi RM, Knoppers BM. Beyond the permissibility of embryonic and stem cell research: substantive requirements and procedural safeguards. Hum Reprod 2006, 21:2474-2481. 10.1093/humrep/del235, 16877375.
8. Isasi R, Knoppers BM. Governing stem cell banks and registries: emerging issues. Stem Cell Res 2009, 3:96-105. 10.1016/j.scr.2009.05.003, 19586808.
9. Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J 2007, 30:373-382. 10.1183/09031936.00165006, 17666560.
10. Stacey GN. Sourcing human embryonic stem cell lines. Human Embryonic Stem Cells: The Practical Handbook 2007, 11-24. New Jersey: John Wiley and Sons, Sullivan S, Cowan CA, Eggan K.
11. Organisation for Economic Co-operation and Development Guidelines for Human Biobanks and Genetic Research Databases (HBGRDs) 2009. Organisation for Economic Co-operation and Development., http://www.oecd.org/document/12/0,3343,en_2649_34537_40302092_1_1_1_1,00.html
12. Burton PR, Hansell AL, Fortier I, Manolio TA, Khoury MJ, Little J, Elliott P. Size matters: just how big is BIG? Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol 2009, 38:263-273. 10.1093/ije/dyn147, 2639365, 18676414.
13. Park A. Ten ideas changing the world right now: biobanks. Time 2009, http://www.time.com/time/specials/packages/article/0,28804,1884779_1884782_1884766,00.html
14. Caulfield T, Scott C, Hyun I, Lovell-Badge R, Kato K, Zarzeczny A. Stem cell research policy and iPS cells. Nat Methods 2010, 7:28-33. 10.1038/nmeth.f.282, 20038953.
15. Lo B, Conklin BR. Consent: criteria should be drawn up for tissue donors. Nature 2009, 461:593. 10.1038/461593b, 19794473.
16. Lipworth W, Irvine R, Morrell B. Consent: a need for guidelines to reflect local considerations. Nature 2009, 461:593. 10.1038/461593c, 19794472.
17. Aalto-Setälä K, Conklin BR, Lo B. Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. PLoS Biol 2009, 7:e42. 10.1371/journal.pbio.1000042, 2652391, 19243222.
18. Lowrance WW, Collins FS. Ethics. Identifiability in genomic research. Science 2007, 317:600-602. 10.1126/science.1147699, 17673640.
19. Lo B, Parham L, Alvarez-Buylla A, Cedars M, Conklin B, Fisher S, Gates E, Giudice L, Halme DG, Hershon W, Kriegstein A, Kwok PY, Wagner R. Cloning mice and men: prohibiting the use of iPS cells for human reproductive cloning. Cell Stem Cell 2010, 6:16-20. 10.1016/j.stem.2009.12.004, 20085739.
20. Knoppers BM, Fortier I, Legault D, Burton P. The Public Population Project in Genomics (P3G): a proof of concept?. Eur J Hum Genet 2008, 16:664-665. 10.1038/ejhg.2008.55, 18382478.
21. Organisation for Economic Co-operation and Development OECD Best Practice Guidelines for Biological Resource Centres, 2007. Organisation for Economic Co-operation and Development., http://www.oecd.org/dataoecd/7/13/38777417.pdf
22. Baust JG. ISBER best practices for repositories and trends at the Institute for Problems of Cryobiology and Medicine. Cell Preserv Technol 2008, 6:1.
23. Borstlap J, Luong MX, Rooke HM, Aran B, Damaschun A, Elstner A, Smith KP, Stein GS, Veiga A. International stem cell registries. In Vitro Cell Dev Biol Anim 2010, 46:242-246. 10.1007/s11626-010-9295-1, 20177992.
24. Zika E, Paci D, Schulte T, Braun A, Rijkers-Defrasne S, Deschênes M, Fortier I, Laage-Hellman J, Scerri CA, Ibarreta I. Biobanks in Europe: prospects for harmonisation and networking. 2010, Seville: European Joint Research Commission and Institute for Prospective Technological Studies., http://ftp.jrc.es/EURdoc/JRC57831.pdf
25. Fortier I, Burton PR, Robson PJ, Ferretti V, Little J, L'heureux F, Deschênes M, Knoppers BM, Doiron D, Keers JC, Linksted P, Harris JR, Lachance G, Boileau C, Pedersen NL, Hamilton CM, Hveem K, Borugian MJ, Gallagher RP, McLaughlin J, Parker L, Potter JD, Gallacher J, Kaaks R, Liu B, Sprosen T, Vilain A, Atkinson SA, Rengifo A, Morton R. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol 2010,
26. International Cancer Genome Consortium Consortium Policies and Guidelines: Informed Consent, Access and Ethical Oversight. International Cancer Genome Consortium., http://www.icgc.org/icgc/goals-structure-policies-guidelines/e1-informed-consent-access-and-ethical-oversight
27. Crook JM, Hei D, Stacey G. The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on. In Vitro Cell Dev Biol Anim 2010, 46:169-172. 10.1007/s11626-010-9301-7, 20195786.
28. International Stem Cell Banking Initiative Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev 2009, 5:301-314. 10.1007/s12015-009-9085-x, 20016957, International Stem Cell Banking Initiative.
29. Zarzeczny A, Scott C, Hyun I, Bennett J, Chandler J, Chargé S, Heine H, Isasi R, Kato K, Lovell-Badge R, McNagny K, Pei D, Rossant J, Surani A, Taylor PL, Ogbogu U, Caulfield T. iPS cells: mapping the policy issues. Cell 2009, 139:1032-1036. 10.1016/j.cell.2009.11.039, 20005794.
30. Lo B, Parham L. Ethical issues in stem cell research. Endocr Rev 2009, 30:204-213. 10.1210/er.2008-0031, 2726839, 19366754.
31. Sugarman J, Siegel AW. Research ethics. When embryonic stem cell lines fail to meet consent standards. Science 2008, 322:379. 10.1126/science.1164441, 18927375.
32. Lo B, Parham L, Broom C, Cedars M, Gates E, Giudice L, Halme DG, Hershon W, Kriegstein A, Kwok PY, Oberman M, Roberts C, Wagner R. Importing human pluripotent stem cell lines derived at another institution: tailoring review to ethical concerns. Cell Stem Cell 2009, 4:115-123. 10.1016/j.stem.2009.01.013, 19200800.
33. Streiffer R. Informed consent and federal funding for stem cell research. Hastings Cent Rep 2008, 38:40-47. 10.1353/hcr.0.0013, 18581936.
34. Editorial: Common consent. Nature 2009, 460:933.
35. Conrad S, Renninger M, Hennenlotter J, Wiesner T, Just L, Bonin M, Aicher W, Bühring HJ, Mattheus U, Mack A, Wagner HJ, Minger S, Matzkies M, Reppel M, Hescheler J, Sievert KD, Stenzl A, Skutella T. Generation of pluripotent stem cells from adult human testis. Nature 2008, 456:344-349. [A published erratum appears in Nature 2009, 460:1044.], 10.1038/nature07404, 18849962.
36. Wadman M. Diseased cells fail to win approval. Nature 2010, 465:852. 10.1038/465852a, 20559353.
37. Tassé AM, Budin-Ljøsne I, Knoppers BM, Harris JR. Retrospective access to data: the ENGAGE consent experience. Eur J Hum Genet 2010, 18:741-745. 10.1038/ejhg.2010.30, 20332813.
38. Pulley J, Clayton E, Bernard GR, Roden DM, Masys DR. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin Transl Sci 2010, 3:42-48. 10.1111/j.1752-8062.2010.00175.x, 20443953.
39. Medical Research Council Code of Practice for the use of Human Stem Cell Lines, April 2010. Medical Research Council., http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC003132
40. Canadian Institutes for Health Research (CIHR) Human Pluripotent Stem Cell Research: Recommendations for CIHR-Funded Research, 2002 (updates published in 2006, 2007 and 2010). Canadian Institutes for Health Research (CIHR)., http://www.cihr-irsc.gc.ca/e/1489.html
41. Interagency Secretariat on Research Ethics Provisional final draft of the tri-council policy statement: ethical conduct for research involving humans (TCPS), 12 May 2010. Interagency Secretariat on Research Ethics., http://www.pre.ethics.gc.ca/eng/policy-politique/initiatives/draft-preliminaire/
42. Homer N, Szelinger S, Redman M, Duggan D, Tembe W, Muehling J, Pearson JV, Stephan DA, Nelson SF, Craig DW. Resolving individuals contributing trace amounts of DNA to highlight complex mixtures using high-density SNP genotyping microarrays. PLoS Genet 2008, 4:e1000167. 10.1371/journal.pgen.1000167, 2516199, 18769715.
43. Lin Z, Altman RB, Owen AB. Genomic research and human subject privacy. Science 2004, 305:183. 10.1126/science.1095019, 15247459.
44. Church G, Heeney C, Hawkins N, de Vries J, Boddington P, Kaye J, Bobrow M, Weir B. P3G consortium Public access to genome-wide data: five views on balancing research with privacy protection. PLoS Genet 2009, 5:e1000665. 10.1371/journal.pgen.1000665, 2749921, 19798440, P3G consortium.
45. Wolfson M, Wallace SE, Masca N, Rowe G, Sheehan NA, Ferretti V, Laflamme P, Tobin MD, Macleod J, Little J, Fortier I, Knoppers BM, Burton PR. DataSHIELD: resolving a conflict in contemporary bioscience - performing a pooled analysis of individual-level data without sharing the data. Int J Epidemiol 2010,
46. Data Protection Working Party Opinion 4/2007 on the Concept of Personal Data. Data Protection Working Party., http://www.gov.gg/ccm/cms-service/download/asset/?asset_id=12058063
47. Miller FA, Hayeems RZ, Bytautas JP. What is a meaningful result? Disclosing the results of genomic research in autism to research participants. Eur J Hum Genet 2010, 18:867-871. 10.1038/ejhg.2010.34, 20234389.
48. Beskow LM, Burke W. Offering individual genetic research results: context matters. Sci Transl Med 2010, 2:38cm20.
49. National Research Council and Institute of Medicine 2010 Amendments to the National Academies' Guidelines for Human Embryonic Stem Cell Research 2010, Washington, DC: The National Academies Press, National Research Council and Institute of Medicine.
50. Instituto de Salud Carlos III, Comité de Ética en la Investigación y de Bienestar Animal Hoja de Información a los Participantes en la Investigación (Document CEI HIPCI_IPS) 2010, Madrid: Instituto de Salud Carlos III, Instituto de Salud Carlos III, Comité de Ética en la Investigación y de Bienestar Animal.
51. Knoppers BM, Saginur M. The Babel of genetic data terminology. Nat Biotechnol 2005, 23:925-927. 10.1038/nbt0805-925, 16082354.
52. U.S. Department of Health and Human Services Food and Drug Administration Guidance for Industry. E15 Definitions for Genomic Biomarkers, Pharmacogenomics, Pharamacogenetics, Genomic Data and Sample Coding Categories. U.S. Department of Health and Human Services Food and Drug Administration., http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073162.pdf
53. American Type Culture Collection Standards Development Organization Workgroup Cell line misidentification: the beginning of the end. Nat Rev Cancer 2010, 10:441-448. 10.1038/nrc2852, 20448633, American Type Culture Collection Standards Development Organization Workgroup.
54. Isasi R. Policy interoperability in stem cell research: demystifying harmonization. Stem Cell Rev 2009, 5:108-115. 10.1007/s12015-009-9067-z, 19521802.
55. International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research. International Society for Stem Cell Research (ISSCR)., http://www.isscr.org/guidelines/ISSCRhESCguidelines2006.pdf
56. Mosher JT, Pemberton TJ, Harter K, Wang C, Buzbas EO, Dvorak P, Simón C, Morrison SJ, Rosenberg NA. Lack of population diversity in commonly used human embryonic stem-cell lines. N Engl J Med 2010, 362:183-185. 10.1056/NEJMc0910371, 20018958.
57. Laurent LC, Nievergelt CM, Lynch C, Fakunle E, Harness JV, Schmidt U, Galat V, Laslett AL, Otonkoski T, Keirstead HS, Schork A, Park HS, Loring JF. Restricted ethnic diversity in human embryonic stem cell lines. Nat Methods 2010, 7:6-7. 10.1038/nmeth0110-06, 20038950.